Salbutamol to facilitate management of acute hyperkalemia in liver transplantation: A case report

Canadian Journal of Anesthesia

Volumn 56, Issue 2, 2009, Pages 142-146

  Kim, Duk Kyung ^a   Chang, Seong Hwan ^a   Yun, Ik Jin ^a   Kwon, Won Kyoung ^a   Woo, Nam Sik ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; POTASSIUM; SALBUTAMOL;

ACUTE DISEASE; ARTICLE; BLOOD; CASE REPORT; CYTOLOGY; HUMAN; HYPERKALEMIA; LIVER; LIVER TRANSPLANTATION; LIVING DONOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PEROPERATIVE COMPLICATION; TIME;

ACUTE DISEASE; ADRENERGIC BETA-AGONISTS; ALBUTEROL; HUMANS; HYPERKALEMIA; INTRAOPERATIVE COMPLICATIONS; LIVER; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POTASSIUM; TIME FACTORS;

EID: 64849105275     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-008-9021-6     Document Type: Article

References (21)

1. Perkins JD. Hyperkalemia and liver transplantation. Liver Transpl 2008; 14: 252-3.
2. Xia VW, Ghobrial RM, Du B, et al. Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg 2007; 105: 780-5.
3. Kim HJ, Han SW. Therapeutic approach to hyperkalemia. Nephron 2002; 92: 33-40.
4. Smith SR, Ryder C, Kendall MJ, Holder R. Cardiovascular and biochemical responses to nebulised salbutamol in normal subjects. Br J Clin Pharmacol 1984; 18: 641-4.
5. Mandelberg A, Krupnik Z, Houri S, et al. Salbutamol metereddose inhaler with spacer for hyperkalemia: How fast? How safe? Chest 1999; 115: 617-22.
6. Liou HH, Chiang SS, Wu SC, et al. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: Comparative study. Am J Kidney Dis 1994; 23: 266-71.
7. Lens XM, Montoliu J, Cases A, Campistol JM, Revert L. Treatment of hyperkalaemia in renal failure: Salbutamol v. insulin. Nephrol Dial Transpl 1989; 4: 228-32.
8. Kim HJ. Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients. J Korean Med Sci 1997; 12: 111-6.
9. Allon M, Dunlay R, Copkney C. Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 1989; 110: 426-9.
10. Kaku R, Matsumi M, Fujii H, et al. A case of severe acute hyperkalemia during pre-anhepatic stage in living-related liver transplantation (Japanese). Masui 2002; 51: 1003-6.
11. Perazella MA, Biswas P. Acute hyperkalemia associated with intravenous epsilon-aminocaproic acid therapy. Am J Kidney Dis 1999; 33: 782-5.
12. Alfonzo AV, Isles C, Geddes C, Deighan C. Potassium disordersclinical spectrum and emergency management. Resuscitation 2006; 70: 10-25.
13. Abouna GM, Skillen A, Hull CJ, Hodson A, Kirkley Jr. A comparison of the effects of warm ischemia and hypothermia on liver glycogen, electrolytes, pH, and subsequent function during perfusion. Br J Surg 1969; 56: 382-3.
14. Jolly PC, Foster JH. Hepatic inflow stasis. Surgery 1963; 54: 45-55.
15. Bengmark S, Hafstrom L, Hultin H, Jagenburg R, Vosmik J. Serum potassium during and following short-term splanchnic ischaemia, short-term hepatic ischaemia, permanent hepatic ischaemia, and total hepatectomy in pigs. Br J Surg 1969; 56: 693-4.
16. Hall RR. Hyperkalaemia following temporary occlusion of the portal vein and hepatic artery. Br J Surg 1972; 59: 125-8.
17. Busque S, Esquivel CO, Concepcion W, So SK. Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. Transplantation 1998; 65: 77-82.
18. Li Q, Zhou MT, Wang Y, et al. Effect of insulin on hyperkalemia during anhepatic stage of liver transplantation. World J Gastroenterol 2004; 10: 2427-9.
19. Kim HJ. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron 1996; 72: 476-82.
20. Allon M, Copkney C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 1990; 38: 869-72.
21. Du Plooy WJ, Hay L, Kahler CP, Schutte PJ, Brandt HD. The dose-related hyper-and hypokalaemic effects of salbutamol and its arrhythmogenic potential. Br J Pharmacol 1994; 111: 73-6.